Medline

Medline Equity

The The Equity of Medline (MDLN) as of Oct 21, 2026 is 10.74 B USD. In the previous year, The Equity was 16.52 B USD — a change of -35.02% (lower).

Equity

10.74 BUSD

YoY

-35.02%

Last updated:

In 2025, Medline's equity was 10.74 B USD, a -35.02% increase from the 16.52 B USD equity in the previous year.

The Medline Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2023
16.98 B USD
Jan 1, 2024
16.52 B USD
Jan 1, 2025
10.74 B USD
The Medline Equity history
YEAREquityYoY
10.74 BUSD-35.02%
16.52 BUSD-2.67%
16.98 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medline Stock analysis

What does Medline do? Medline Inc generates revenue through its Medline Brand and Supply Chain Solutions segments. The Medline Brand offers approximately 335,000 medical-surgical products organized into Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories, serving hospitals, surgery centers, physician offices, and post-acute facilities. Supply Chain Solutions procures and distributes third-party products from national brands while providing tailored logistics and supply chain optimization services to domestic and international customers. The company's mission-critical products include surgical and procedural kits, gloves, protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Medline Brand products target healthcare facilities requiring daily mission-critical supplies, with Front Line Care focusing on immediate patient care needs, Surgical Solutions supporting operating rooms, and Laboratory and Diagnostics serving clinical testing environments. Supply Chain Solutions serves as a distribution partner for national brands, offering logistics expertise to optimize supply chains for healthcare providers across various care settings. The company's product portfolio supports all points of care, from acute to post-acute facilities, ensuring consistent product availability for daily operations. Customers purchasing Medline Brand products include hospitals, surgery centers, physician offices, and post-acute facilities, while Supply Chain Solutions serves domestic and international clients needing third-party product distribution and supply chain services. The firm's offerings cover the full range of care settings, with Surgical Solutions specifically targeting operating room environments and Laboratory and Diagnostics supporting clinical laboratories. Medline's product range ensures healthcare providers have access to essential supplies without disruption in daily operations. Medline is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Medline's Equity

Medline's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Medline's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Medline's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Medline's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Medline’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Medline stock

The Equity of Medline is 10.74 B USD in 2025.

The Equity of Medline changed from 16.52 B USD to 10.74 B USD, representing a -35.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Medline since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Medline historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Medline

All Key Metrics — Medline